Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Miromatrix Medical Inc. - Common Stock
(NQ:
MIRO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 12, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Miromatrix Medical Inc. - Common Stock
< Previous
1
2
Next >
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
December 13, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
December 12, 2023
From
United Therapeutics Corporation
Via
Business Wire
MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO
November 15, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Miromatrix Medical Inc. (NASDAQ: MIRO) Near the Top of Equities by Percentage Gain on 10/30
October 30, 2023
Via
Investor Brand Network
Miromatrix Reports Third Quarter 2023 Results
November 14, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
November 13, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO
November 01, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
October 30, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
MIRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Miromatrix Medical Inc. Is Fair to Shareholders
October 30, 2023
From
Halper Sadeh LLC
Via
Business Wire
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
United Therapeutics Corporation
Via
Business Wire
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
October 11, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
October 05, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference
September 06, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop
September 05, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
August 14, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix to Report Second Quarter 2023 Financial Results
July 25, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award
July 13, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D
June 01, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Presenting at the 2023 American Transplant Congress
May 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
May 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
May 11, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix to Report First Quarter 2023 Financial Results
April 27, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
April 10, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
April 05, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
April 05, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
March 31, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
March 07, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
March 07, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.